common glp 1 agonist agonists GLP-1 Agonists What Are GLP-1 Agonists For

In obesity management, GLP-1RAs in general, and semaglutide in particular, have been shown to induce significant and sustained weight loss in clinical trials (4)

These results are in alignment with those of Mitchell et al

Finally, vasoactive substances produced by vascular endothelial cells are also important factors in the regulation of blood pressure

For many people living with obesity, this level of weight loss is not just cosmetic, it reduces the risk of heart disease, joint pain, improves mobility and boosts quality of life

Eur J Pharmacol (2013) 700:4250

In addition to aforementioned properties of GLP-1 agonists, it can also reduce hypertension by activating and phosphorylating endothelial nitric oxide synthase pathways, thus increasing the bioavailability of nitric oxide which promotes vasodilation